Patent Term Extension Application for LIFYORLI® (relacorilant), Patent No. 9,273,047 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-8229

Patent Term Extension Application for LIFYORLI® (relacorilant), Patent No. 9,273,047

Documents

Comments

Description

OPEN

Comment Period OpensJul 30, 2026

Type	Title	Posted	Comments	Status
Other	Patent Term Extension Application from Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (on behalf of Corcept Therapeutics Incorporated)	Jul 30, 2026	--

CDER

Patent Term Extension Application for LIFYORLI®

Mintz, Levin, Cohn, Ferris,

Glovsky and Popeo, P.C.

Corcept Therapeutics Incorporated

(relacorilant)

Patent No. 9,273,047

OPEN